These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 27165830

  • 1. Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney.
    Lin CH, Chen J, Zhang Z, Johnson GV, Cooper AJ, Feola J, Bank A, Shein J, Ruotsalainen HJ, Pihlajaniemi TA, Goligorsky MS.
    Kidney Int; 2016 Jun; 89(6):1281-92. PubMed ID: 27165830
    [Abstract] [Full Text] [Related]

  • 2. Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration.
    Shweke N, Boulos N, Jouanneau C, Vandermeersch S, Melino G, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ.
    Am J Pathol; 2008 Sep; 173(3):631-42. PubMed ID: 18688035
    [Abstract] [Full Text] [Related]

  • 3. Feline chronic kidney disease is associated with upregulation of transglutaminase 2: a collagen cross-linking enzyme.
    Sánchez-Lara AC, Elliott J, Syme HM, Brown CA, Haylor JL.
    Vet Pathol; 2015 May; 52(3):513-23. PubMed ID: 25047228
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.
    Scarpellini A, Huang L, Burhan I, Schroeder N, Funck M, Johnson TS, Verderio EA.
    J Am Soc Nephrol; 2014 May; 25(5):1013-27. PubMed ID: 24357671
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endostatin, an antiangiogenic protein, is expressed in the unilateral ureteral obstruction mice model.
    Maciel TT, Coutinho EL, Soares D, Achar E, Schor N, Bellini MH.
    J Nephrol; 2008 May; 21(5):753-60. PubMed ID: 18949731
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
    Stamnaes J, Cardoso I, Iversen R, Sollid LM.
    FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
    [Abstract] [Full Text] [Related]

  • 10. Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis.
    Tatsukawa H, Otsu R, Tani Y, Wakita R, Hitomi K.
    Sci Rep; 2018 May 09; 8(1):7306. PubMed ID: 29743665
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage.
    Pufe T, Petersen WJ, Miosge N, Goldring MB, Mentlein R, Varoga DJ, Tillmann BN.
    Matrix Biol; 2004 Aug 09; 23(5):267-76. PubMed ID: 15464359
    [Abstract] [Full Text] [Related]

  • 13. Collagen XVIII/endostatin expression in experimental endotoxemic acute renal failure.
    Cichy MC, Rocha FG, Tristão VR, Pessoa EA, Cenedeze MA, Nürmberg Junior R, Schor N, Bellini MH.
    Braz J Med Biol Res; 2009 Dec 09; 42(12):1150-5. PubMed ID: 19893988
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice.
    Popov Y, Sverdlov DY, Sharma AK, Bhaskar KR, Li S, Freitag TL, Lee J, Dieterich W, Melino G, Schuppan D.
    Gastroenterology; 2011 May 09; 140(5):1642-52. PubMed ID: 21277850
    [Abstract] [Full Text] [Related]

  • 16. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
    Salter NW, Ande SR, Nguyen HK, Nyomba BL, Mishra S.
    J Mol Endocrinol; 2012 Jun 09; 48(3):203-16. PubMed ID: 22394545
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Upregulation of transglutaminase and ε (γ-glutamyl)-lysine in the Fisher-Lewis rat model of chronic allograft nephropathy.
    Shrestha B, Butt I, Da Silva M, Sanchez-Lara A, Wagner B, Raftery A, Johnson T, Haylor J.
    Biomed Res Int; 2014 Jun 09; 2014():651608. PubMed ID: 25143942
    [Abstract] [Full Text] [Related]

  • 19. Does treatment with corticosteroids and cyclosporine reduce transglutaminase type 2 expression in the renal tissue of patients with membranous nephropathy?
    Papasotiriou M, Kalliakmani P, Huang L, Gerolymos M, Goumenos DS, Johnson TS.
    Nephron Clin Pract; 2012 Jun 09; 121(1-2):c60-7. PubMed ID: 23107829
    [Abstract] [Full Text] [Related]

  • 20. CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer.
    Min B, Park H, Lee S, Li Y, Choi JM, Lee JY, Kim J, Choi YD, Kwon YG, Lee HW, Bae SC, Yun CO, Chung KC.
    Oncogene; 2016 Jul 14; 35(28):3718-28. PubMed ID: 26568304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.